Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Pediatrics
78%
Chemotherapy
50%
Leukemia
30%
Lymphocyte
23%
Platelet
22%
Neutrophil
21%
Hematology
20%
Thalassemia
19%
Retrospective Study
19%
Adolescence
16%
Cross Sectional Study
15%
Childhood Cancer
15%
Prevalence
14%
Leukocyte
14%
Hepatomegaly
12%
Methotrexate
11%
Induction Chemotherapy
11%
Diseases
11%
Acute Lymphocytic Leukemia
10%
Ferritin
9%
Thrombocyte Transfusion
9%
Hospital-Acquired Pneumonia
9%
Protein Bcl 2
9%
Protein Expression
9%
Exchange Blood Transfusion
9%
Liposomal Daunorubicin
9%
Cardiotoxicity
9%
Tumor Lysis Syndrome
9%
Solid Malignant Neoplasm
9%
Burkitt's Lymphoma
9%
Somatomedin C
9%
Leukemia in Children
9%
Myeloid Leukemia
9%
High Risk Population
9%
Kidney Function
9%
Pneumonia
9%
Caspase 3
9%
Social Support
9%
Drug Megadose
9%
Metabolic Syndrome
9%
Lung Tuberculosis
9%
Insulin Resistance
9%
Hyperactivity
9%
Peer Group
9%
Febrile Neutropenia
9%
Hemoglobins
8%
Community-Acquired Pneumonia
7%
Anemia
7%
Neutropenia
6%
Keyphrases
Acute Lymphoblastic Leukemia
51%
Transfusion-dependent Thalassemia
49%
Chemotherapy
30%
Pediatric Acute Lymphoblastic Leukemia
26%
Serum Ferritin
26%
Ferritin Levels
22%
Risk Factors
21%
Induction Period
20%
Childhood Acute Lymphoblastic Leukemia
18%
Hemoglobin Level
17%
Standard Risk
16%
Surabaya
15%
Blood Transfusion
15%
Thalassemia
12%
L-asparaginase
11%
Oncohematology
11%
Thalassemia children
11%
General Hospital
11%
Pediatric Leukemia
11%
Hepcidin Levels
10%
Platelet Refractoriness
9%
Corrected Count Increment
9%
Platelet Concentrate Transfusion
9%
Pediatric Oncology
9%
Laboratory Effects
9%
Body Segment
9%
Bcl-2 Family Proteins
9%
High-dose Methotrexate (HD-MTX)
9%
Pediatric Transfusion
9%
Hyperleukocytosis
9%
Clinical Effect
9%
Neutrophil-to-lymphocyte Ratio
9%
Protein Expression
9%
Methotrexate Chemotherapy
9%
Hepatotoxicity
9%
Growth Status
9%
Alloimmunization
9%
Autoimmunization
9%
Platelet-to-lymphocyte Ratio
9%
Ketorolac
9%
Insulin-like
9%
Pediatric Tumors
9%
HAMP Gene
9%
Myeloid Leukemia
9%
Learning Environment Perceptions
9%
Unveiling
9%
Height-for-age
9%
Discriminative Performance
9%
Induced Gastric Ulcers
9%
Lipid Profile
9%
Nursing and Health Professions
Thalassemia
39%
Acute Lymphoblastic Leukemia
31%
Pediatrics
23%
Platelet Lymphocyte Ratio
19%
Neutrophil Lymphocyte Ratio
18%
Ferritin Blood Level
16%
Blood Transfusion
15%
Youth
14%
Neutrophil
13%
Leukemia
12%
Hyperactivity
9%
Psychosocial Aspect
9%
Protein Bcl 2
9%
Burkitt's Lymphoma
9%
Prevalence
9%
Quality of Life
9%
Chemotherapy
9%
General Hospital
9%
Hepcidin
9%
Alloimmunization
9%
Daunorubicin
9%
Insulin Resistance
9%
Myeloid Leukemia
9%
Interleukin 6
9%
Metabolic Syndrome X
9%
Hematology Analyzer
9%
Sepsis
9%
Peer Group
9%
Lymphocyte Monocyte Ratio
9%
Mean Platelet Volume
9%
Ferritin
8%
Cross-Sectional Study
7%
Iron Poisoning
6%
Leukocyte Count
5%
Deferiprone
5%
Body Mass
5%
Malignant Neoplasm
5%